| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $396.3M | +242.2% |
| Cost of Revenue | $93.6M | +160.2% |
| Gross Profit | $302.7M | +279.2% |
| R&D Expense | $200.8M | +173.6% |
| SG&A Expense | $94.3M | +492.0% |
| Operating Income | -$116.1M | -293.5% |
| Pre-tax Income | -$81.8M | -256.4% |
| Income Tax | $1.6M | -50.3% |
| Net Income | -$83.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $79.6M | +76.4% |
| Accounts Receivable | $38.8M | +365.6% |
| Inventory | $43.2M | +79.4% |
| Current Assets | $1.01B | +445.2% |
| Total Assets | $1.05B | +437.2% |
| Current Liabilities | $86.5M | +146.7% |
| Total Liabilities | $89.7M | +130.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $136.7M | +1174.8% |
| Capital Expenditures | $34.2M | +1140.3% |
| Investing Cash Flow | -$757.6M | -4162.7% |
| Financing Cash Flow | $655.8M | — |
| Free Cash Flow | $102.4M | +761.8% |
| -217.7% |
| EPS (Basic) | -$0.64 | +9.9% |
| EPS (Diluted) | -$0.64 | +9.9% |
| Stockholders' Equity |
| $964.8M |
| +1087.5% |